FOXC1 and osteoarthritis: Subsequently, EP300 binds to the FOXC1 promoter and promotes the enrichment of H3K27Ac at the FOXC1 promoter to elevate FOXC1 expression, ultimately regulating IL‐1β‐induced chondrocyte damage and promoting the progression of osteoarthritis.